The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of 68Ga-DOTATATE for evaluation of patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Mehmet Asim Bilen
Consulting or Advisory Role - Eisai; EMD Serono; Exelixis; Genomic Health; Janssen; Nektar; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)
 
Akinyemi A Akintayo
No Relationships to Disclose
 
Olayinka A. Abiodun-Ojo
No Relationships to Disclose
 
Omer Kucuk
No Relationships to Disclose
 
Bradley Curtis Carthon
Consulting or Advisory Role - Eisai
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David M. Schuster
Employment - DigiRad (I)
Consulting or Advisory Role - AIM Specialty Health; Syncona
Research Funding - Advanced Accelerator Applications (Inst); Blue Earth Diagnostics (Inst); Nihon Medi-Physics (Inst); Telix Pharmaceuticals (Inst)
 
Ephraim E Parent
Research Funding - Advanced Accelerator Applications (Inst)